NDC 15631-0125

CHENOPODIUM ANTHELMINTICUM

Chenopodium Anthelminticum

CHENOPODIUM ANTHELMINTICUM is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Dysphania Ambrosioides.

Product ID15631-0125_a093a8cc-575f-1da3-e053-2a95a90ad74a
NDC15631-0125
Product TypeHuman Otc Drug
Proprietary NameCHENOPODIUM ANTHELMINTICUM
Generic NameChenopodium Anthelminticum
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-10-02
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameDYSPHANIA AMBROSIOIDES
Active Ingredient Strength1 [hp_X]/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 15631-0125-0

100 PELLET in 1 PACKAGE (15631-0125-0)
Marketing Start Date2018-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0125-1 [15631012501]

CHENOPODIUM ANTHELMINTICUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-13

NDC 15631-0125-4 [15631012504]

CHENOPODIUM ANTHELMINTICUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-13

NDC 15631-0125-2 [15631012502]

CHENOPODIUM ANTHELMINTICUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-13

NDC 15631-0125-5 [15631012505]

CHENOPODIUM ANTHELMINTICUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-13

NDC 15631-0125-3 [15631012503]

CHENOPODIUM ANTHELMINTICUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-13

NDC 15631-0125-0 [15631012500]

CHENOPODIUM ANTHELMINTICUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-13

Drug Details

Active Ingredients

IngredientStrength
DYSPHANIA AMBROSIOIDES1 [hp_X]/1

OpenFDA Data

SPL SET ID:1c4774d1-5720-4df6-8bdd-e8473745178c
Manufacturer
UNII

NDC Crossover Matching brand name "CHENOPODIUM ANTHELMINTICUM" or generic name "Chenopodium Anthelminticum"

NDCBrand NameGeneric Name
0220-1293Chenopodium anthelminticumDYSPHANIA AMBROSIOIDES
15631-0125CHENOPODIUM ANTHELMINTICUMCHENOPODIUM ANTHELMINTICUM
63545-475Chenopodium AnthelminticumChenopodium Anthelminticum
63545-476Chenopodium AnthelminticumChenopodium Anthelminticum
63545-477Chenopodium AnthelminticumChenopodium Anthelminticum
63545-478Chenopodium AnthelminticumChenopodium Anthelminticum
63545-479Chenopodium AnthelminticumChenopodium Anthelminticum
63545-480Chenopodium AnthelminticumChenopodium Anthelminticum
63545-481Chenopodium AnthelminticumChenopodium Anthelminticum
68428-304Chenopodium anthelminticumCHENOPODIUM AMBROSIOIDES
71919-182Chenopodium anthelminticumDYSPHANIA AMBROSIOIDES

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.